abiraterone,olaparib
merck,astrazeneca
['abiraterone', 'crpc', 'propel', 'abira', 'olaparib']
health-related quality of life and pain outcomes for patients with #mcrpc who received abiraterone and olaparib vs abi and placebo in the phase iii #propel trial. presented by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology